MR BIOINVEST ApS: Financial statements 2022
CVR: 25942817
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
MR BIOINVEST ApS (CVR 25942817) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -27,500 and a net result of DKK -2,554,036 compared with DKK 2,745,721 the year before. Equity in the 2022 report amounted to DKK 23,183,275. The solvency ratio was 96.7%.
- Gross Profit
- DKK -27,500
- Profit/Loss
- DKK -2,554,036
- Equity
- DKK 23,183,275
- Total Assets
- DKK 23,977,308
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -28K | -2.6M | 23.2M | 0 |
| 2021 | - | -34K | 2.7M | 25.7M | 0 |
| 2020 | - | -83K | -102K | 23M | 0 |
| 2019 | - | -33K | 2.9M | 23.1M | 0 |
| 2018 | - | -63K | -1.4M | 20.2M | 0 |
Official annual report
Keep an eye on MR BIOINVEST ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
MR BIOINVEST ApS has published its annual report for 2021. Gross profit came to DKK -34,375, and the net result was DKK 2,745,721.
About MR BIOINVEST ApS
MR BIOINVEST ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2001. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Mads Aage Laustsen. The company is owned by Mads Aage Laustsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,875 and a net result of DKK 1,503,262 compared with DKK 1,669,196 the year before. Equity in the 2025 report amounted to DKK 28,217,549.
